Brekiya (dihydroergotamine mesylate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.
Brekiya is a type of ergot medicine used to treat migraine attacks in adults. It works by attaching to serotonin receptors, which are docking sites on certain cells. This affects blood vessel and nerve signaling linked to migraine attacks.
Doctors prescribe Brekiya when a migraine attack begins and acute treatment is needed for migraine with or without aura in adults.
Brekiya is given as an injection under the skin using a single-dose autoinjector. The dose may be repeated, if needed, at one-hour intervals. With proper training, individuals may use the autoinjector at home.
The recommended dose of Brekiya for acute migraine treatment is 1 milligram injected under the skin using a prefilled, single-dose disposable autoinjector. Brekiya is intended to be injected into the skin of the middle thigh.
The dose may be repeated as needed, up to 3 milligrams in 24 hours. Do not use more than 6 milligrams in one week.
This information is based on the prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.
Brekiya can cause side effects. Some side effects have been reported in clinical studies and after the medicine became available for use. Reported side effects include:
Brekiya can cause serious side effects that may require immediate medical attention. These include:
Get medical help right away if you think you are having a serious reaction.
Amneal Pharmaceuticals, the manufacturer of Brekiya, offers a Copay Program. Eligible people with commercial insurance may pay as little as $40 per carton.
The Copay Program offers automatic enrollment for qualified commercially insured people through participating specialty pharmacies, with no cards or coupons needed.
To learn more, visit the How To Get Brekiya page or contact the participating specialty pharmacies listed by the manufacturer: Sterling Specialty Pharmacy at 888-618-4126 or Walgreens Specialty Pharmacy at 888-282-5166.
Before starting Brekiya, your doctor may do a cardiovascular evaluation to check your heart health.
Tell your doctor if you have any allergies to dihydroergotamine mesylate, ergot alkaloids, latex, or any ingredients in Brekiya. Do not take Brekiya if you have had an allergic reaction to dihydroergotamine, ergot alkaloids, latex, or any ingredient in Brekiya.
Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Do not take Brekiya if you:
Brekiya is also FDA-approved for the acute treatment of cluster headaches in adults.
If you are pregnant, planning to become pregnant, or breastfeeding while taking Brekiya, talk with your doctor about the risks and benefits. Avoid use during pregnancy.
Do not breastfeed during treatment and for three days after your last dose. Pump and discard breast milk during this time.
These answers are fact-checked by our editorial staff.
How effective is Brekiya?
Brekiya is approved to treat migraine attacks with or without aura in adults. It is also approved to treat cluster headaches in adults. Brekiya works by affecting certain signals in the body linked to migraine attacks.
Brekiya is used after a migraine starts and is not meant to prevent migraine before it happens. People may respond differently to treatment. Talk with your doctor about whether Brekiya may be right for you.
How long does Brekiya take to work for a migraine?
The study results do not say exactly how quickly Brekiya relieves migraine symptoms. After the injection, the medicine reached its highest level in the blood in about 24 minutes in a study.
Brekiya is used to treat migraine attacks after they begin. Follow your doctor’s instructions on when and how to use it.
Can Brekiya be used with other medicines for migraine?
Brekiya may interact with some medications used for migraine and other conditions. Do not use Brekiya within 24 hours of taking a triptan medicine or another ergot-containing or ergot-type medicine because this may increase the risk of serious side effects.
Brekiya should also not be used with strong CYP3A4 inhibitors or with peripheral or central vasoconstrictors.
Tell your doctor about all medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements, before starting Brekiya.
On MyMigraineTeam, people share their experiences with migraine, get advice, and find support from others who understand.
Learn more about Brekiya and migraine care:
Become a member to get even more